CorMedix Inc. Daily Stock Analysis

Daily Stock Analysis, CRMD, CorMedix Inc, priceseries

CorMedix Inc. Daily Stock Analysis
Stock Information
Open
4.53
Close
4.36
High
4.54
Low
4.27
Previous Close
4.47
Daily Price Gain
-0.11
YTD High
5.07
YTD High Date
Mar 1, 2022
YTD Low
3.65
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.49
YTD Gain
-10.10%
52 Week High
10.60
52 Week High Date
Mar 22, 2021
52 Week Low
3.65
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-2.49
52 Week Gain
-36.35%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 1. 2017
8.85
Feb 22. 2017
10.94
14 Trading Days
23.57%
Link
LONG
Jun 2. 2017
2.20
Jun 6. 2017
2.31
2 Trading Days
5.09%
Link
LONG
Aug 23. 2017
2.02
Sep 5. 2017
2.22
8 Trading Days
9.84%
Link
LONG
Sep 21. 2017
2.11
Oct 13. 2017
3.20
16 Trading Days
51.54%
Link
LONG
May 30. 2018
1.15
Jun 12. 2018
1.40
9 Trading Days
22.67%
Link
LONG
Jul 26. 2018
2.15
Aug 8. 2018
2.76
9 Trading Days
28.35%
Link
LONG
Sep 20. 2018
3.08
Oct 18. 2018
8.60
20 Trading Days
179.47%
Link
LONG
Dec 4. 2018
6.75
Dec 11. 2018
7.15
4 Trading Days
5.93%
Link
LONG
Jan 2. 2019
6.95
Jan 18. 2019
8.25
12 Trading Days
18.78%
Link
LONG
Feb 8. 2019
9.85
Feb 14. 2019
10.70
4 Trading Days
8.63%
Link
LONG
Mar 27. 2019
9.27
Mar 28. 2019
9.88
1 Trading Days
6.63%
Link
LONG
Nov 15. 2019
5.56
Nov 26. 2019
5.85
7 Trading Days
5.22%
Link
LONG
Apr 9. 2020
3.57
Apr 30. 2020
4.19
14 Trading Days
17.31%
Link
LONG
May 20. 2020
4.13
May 29. 2020
4.43
6 Trading Days
7.19%
Link
LONG
Jun 1. 2020
4.60
Jun 11. 2020
5.52
8 Trading Days
19.96%
Link
LONG
Aug 14. 2020
4.35
Aug 27. 2020
4.70
9 Trading Days
8.09%
Link
LONG
Sep 28. 2020
5.38
Oct 14. 2020
5.89
12 Trading Days
9.51%
Link
LONG
Nov 10. 2020
5.58
Dec 11. 2020
8.35
22 Trading Days
49.60%
Link
LONG
Jan 6. 2021
7.94
Jan 21. 2021
8.64
10 Trading Days
8.83%
Link
LONG
Feb 2. 2021
11.72
Feb 5. 2021
12.93
3 Trading Days
10.28%
Link
LONG
Feb 12. 2021
13.74
Feb 23. 2021
14.65
6 Trading Days
6.63%
Link
LONG
Jun 4. 2021
7.45
Jun 17. 2021
7.94
9 Trading Days
6.59%
Link
Company Information
Stock Symbol
CRMD
Exchange
NYSE MKT
Company URL
http://www.cormedix.com
Company Phone
908-517-9500
CEO
Mohammed Khoso Baluch
Headquarters
New Jersey
Business Address
1430 HIGHWAY 206, SUITE 200, BEDMINSTER, NJ 07921
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001410098
About

CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Bridgewater, NJ.

Description

CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and other markets. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading